ロード中...
Use of Oral Concomitant Medications in Patients With Acromegaly
Background: Acromegaly is a rare condition characterized by excess GH and IGF-I levels.(1) Injectable somatostatin analogs (SSAs) are recommended as first-line medical treatment.(2) Comorbidities including diabetes, hypertension and hypopituitarism reduce quality of life in patients with acromegaly;...
保存先:
| 出版年: | J Endocr Soc |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090642/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1076 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|